Release Date: 01/08/11 09:18 Summary: Appendix 5b June Quarter Price Sensitive: Yes Download Document 276.43KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%